Skip to main content
KMDA
NASDAQ Life Sciences

Kamada Reports Q4 EPS of $0.06, Revenue Misses Analyst Estimates

feedReported by Reuters
Sentiment info
Negative
Importance info
7
Price
$8.6
Mkt Cap
$516.827M
52W Low
$5.54
52W High
$9.35
Market data snapshot near publication time

summarizeSummary

Kamada reported fourth-quarter earnings per share of $0.06 and net income of $3.6 million. The company's Q4 revenue came in at $44.7 million, falling short of the IBES estimate of $45.4 million. This revenue miss, while modest, could negatively impact investor sentiment and is a key metric for traders. Investors will now focus on any forward-looking statements or guidance provided by management regarding the company's outlook.

At the time of this announcement, KMDA was trading at $8.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $516.8M. The 52-week trading range was $5.54 to $9.35. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


show_chartPrice Chart

Share this article

Copied!

feed KMDA - Latest Insights

KMDA
Mar 31, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
KMDA
Mar 26, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
KMDA
Mar 11, 2026, 7:24 AM EDT
Filing Type: 20-F
Importance Score:
8
KMDA
Mar 11, 2026, 7:02 AM EDT
Source: Reuters
Importance Score:
7
KMDA
Jan 07, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
8